GRI Bio, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.20 | $-0.91 | +24.2% | Beat |
| Q12026 FY2026 | $-0.91 | $-1.61 | -76.9% | Miss |
| Q12026 FY2026 | $-29.27 | — | — | Miss |
Back to GRI overview · GRI holders · GRI KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.